Cite
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.
MLA
Fanale, Daniele, et al. “Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.” Cancers, vol. 12, no. 9, Sept. 2020, p. 2415. EBSCOhost, https://doi.org/10.3390/cancers12092415.
APA
Fanale, D., Incorvaia, L., Filorizzo, C., Bono, M., Fiorino, A., Calò, V., Brando, C., Corsini, L. R., Barraco, N., Badalamenti, G., Russo, A., & Bazan, V. (2020). Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2. Cancers, 12(9), 2415. https://doi.org/10.3390/cancers12092415
Chicago
Fanale, Daniele, Lorena Incorvaia, Clarissa Filorizzo, Marco Bono, Alessia Fiorino, Valentina Calò, Chiara Brando, et al. 2020. “Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.” Cancers 12 (9): 2415. doi:10.3390/cancers12092415.